Synonyms: MMV688978 | Ridaura® | SK&F-39162 | SK-39162
auranofin is an approved drug (FDA (1985))
Compound class:
Synthetic organic
Comment: Auranofin is a gold-containing complex, antirheumatic agent. It demonstrates potent antibacterial activity in vitro against Gram-positive bacteria and both replicating and nonreplicating Mycobacterium tuberculosis [2].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Gromer S, Arscott LD, Williams Jr CH, Schirmer RH, Becker K. (1998)
Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem, 273 (32): 20096-101. [PMID:9685351] |
2. Harbut MB, Vilchèze C, Luo X, Hensler ME, Guo H, Yang B, Chatterjee AK, Nizet V, Jacobs Jr WR, Schultz PG et al.. (2015)
Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proc Natl Acad Sci U S A, 112 (14): 4453-8. [PMID:25831516] |
3. Hatano N, Suzuki H, Muraki Y, Muraki K. (2013)
Stimulation of human TRPA1 channels by clinical concentrations of the antirheumatic drug auranofin. Am J Physiol, Cell Physiol, 304 (4): C354-61. [PMID:23220116] |